Precise
发表于 2025-3-21 16:31:45
书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0426564<br><br> <br><br>书目名称High-Density Lipoproteins as Biomarkers and Therapeutic Tools读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0426564<br><br> <br><br>
HEW
发表于 2025-3-21 23:36:48
HDL as Therapeutic Tools,thout any observed toxicity at therapeutic doses (Oda et al. 2006). These reports have demonstrated that rHDL might be utilized as efficient drug and gene delivery vehicles for therapeutic agents, owing to the ability of peripheral cells to acquire HDL core components.
companion
发表于 2025-3-22 03:35:39
ific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of inter978-981-13-7385-5978-981-13-7383-1
pacific
发表于 2025-3-22 04:36:06
High-Density Lipoproteins as Biomarkers and Therapeutic ToolsVolume 2. Improvemen
Hemoptysis
发表于 2025-3-22 11:03:18
High-Density Lipoproteins as Biomarkers and Therapeutic Tools978-981-13-7383-1
thrombus
发表于 2025-3-22 15:29:13
http://reply.papertrans.cn/43/4266/426564/426564_6.png
Osteons
发表于 2025-3-22 18:42:41
http://reply.papertrans.cn/43/4266/426564/426564_7.png
怪物
发表于 2025-3-22 23:12:29
Enhancement of HDL by Policosanol,8) and increased longevity (Mazzotti et al. 2014; Milman et al. 2014). Policosanol (PCO) supplementation is widely used in Central America and Latin America to treat dyslipidemia and manage cardiovascular burden. PCO is mixture of eight aliphatic primary alcohols refined from sugarcane wax (. L.). I
TERRA
发表于 2025-3-23 02:08:50
http://reply.papertrans.cn/43/4266/426564/426564_9.png
Afflict
发表于 2025-3-23 07:17:44
Book 2019he changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date